(Q81156941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

11

Jürgen C Becker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Kerstin Otto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Mads Hald Andersen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Andreas Eggert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Petra Keikavoussi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Lars Østergaard Pedersen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Jörg C Rath

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Markus Böck

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Eva-B Bröcker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Per Thor Straten

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Eckhart Kämpgen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

884-889

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

Biochemotherapy for advanced melanoma

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Mutations of the BRAF gene in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Immunobiology of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

The molecular basis and potential role of survivin in cancer diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Validating survivin as a cancer therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Inhibition of melanoma tumor growth in vivo by survivin targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

Inhibitor of apoptosis protein survivin regulates vascular injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.007

10.1016/J.VACCINE.2004.08.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15603888%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference